> top > docs > PMC:7306567 > spans > 17076-17321 > annotations

PMC:7306567 / 17076-17321 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T20 7-13 Body_part denotes plasma http://purl.org/sig/ont/fma/fma62970

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
192 21-33 Chemical denotes voriconazole MESH:D065819
195 229-244 Disease denotes (neuro)toxicity MESH:C536203

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T81 132-134 Disease denotes IA http://purl.obolibrary.org/obo/MONDO_0000240

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T110 7-13 http://purl.obolibrary.org/obo/UBERON_0001969 denotes plasma
T111 140-141 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T118 21-33 Chemical denotes voriconazole http://purl.obolibrary.org/obo/CHEBI_10023
T119 132-134 Chemical denotes IA http://purl.obolibrary.org/obo/CHEBI_74062

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T114 0-245 Sentence denotes Target plasma trough voriconazole concentrations of ≥ 1.5–2 mg/L are associated with near-maximal clinical response in treatment of IA with a wild-type phenotype [46–51], with higher exposures (> 5.5 mg/L) increasing the risk of (neuro)toxicity.

LitCovid-PMC-OGER-BB

Id Subject Object Predicate Lexical cue
T137 7-13 UBERON:0001969 denotes plasma
T138 21-33 CHEBI:10023;CHEBI:10023 denotes voriconazole
T6563 7-13 UBERON:0001969 denotes plasma
T68072 21-33 CHEBI:10023;CHEBI:10023 denotes voriconazole

2_test

Id Subject Object Predicate Lexical cue
32572532-22610925-47963439 163-165 22610925 denotes 46
32572532-18171251-47963439 163-165 18171251 denotes 46
32572532-21768513-47963439 163-165 21768513 denotes 46
32572532-22751544-47963439 163-165 22751544 denotes 46
T88155 163-165 22610925 denotes 46
T71393 163-165 18171251 denotes 46
T75852 163-165 21768513 denotes 46
T42515 163-165 22751544 denotes 46